Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

749 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vedolizumab for children with intestinal graft-versus-host disease: a case report and literature review.
Fukuta T, Muramatsu H, Yamashita D, Sajiki D, Maemura R, Tsumura Y, Yamamori A, Imaya M, Wakamatsu M, Nishikawa E, Narita K, Kataoka S, Taniguchi R, Narita A, Nishio N, Takahashi Y. Fukuta T, et al. Among authors: narita k, narita a. Int J Hematol. 2023 Sep;118(3):411-417. doi: 10.1007/s12185-023-03590-2. Epub 2023 Apr 19. Int J Hematol. 2023. PMID: 37074509 Review.
MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents.
Suzuki K, Okuno Y, Kawashima N, Muramatsu H, Okuno T, Wang X, Kataoka S, Sekiya Y, Hamada M, Murakami N, Kojima D, Narita K, Narita A, Sakaguchi H, Sakaguchi K, Yoshida N, Nishio N, Hama A, Takahashi Y, Kudo K, Kato K, Kojima S. Suzuki K, et al. Among authors: narita k, narita a. J Clin Oncol. 2016 Oct 1;34(28):3451-9. doi: 10.1200/JCO.2016.66.5547. Epub 2016 Aug 9. J Clin Oncol. 2016. PMID: 27507882
Allogeneic stem cell transplantation with reduced intensity conditioning for patients with adrenoleukodystrophy.
Kato K, Maemura R, Wakamatsu M, Yamamori A, Hamada M, Kataoka S, Narita A, Miwata S, Sekiya Y, Kawashima N, Suzuki K, Narita K, Doisaki S, Muramatsu H, Sakaguchi H, Matsumoto K, Koike Y, Onodera O, Kaga M, Shimozawa N, Yoshida N. Kato K, et al. Among authors: narita k, narita a. Mol Genet Metab Rep. 2018 Nov 20;18:1-6. doi: 10.1016/j.ymgmr.2018.11.001. eCollection 2019 Mar. Mol Genet Metab Rep. 2018. PMID: 30519529 Free PMC article.
Comparison of high-dose and low-dose corticosteroid therapy for refractory Mycoplasma pneumoniae pneumonia in children.
Okumura T, Kawada JI, Tanaka M, Narita K, Ishiguro T, Hirayama Y, Narahara S, Tsuji G, Sugiyama Y, Suzuki M, Tsuji T, Hoshino S, Nakatochi M, Muramatsu H, Kidokoro H, Takahashi Y, Sato Y; Nagoya Collaborative Clinical Research Team. Okumura T, et al. Among authors: narita k. J Infect Chemother. 2019 May;25(5):346-350. doi: 10.1016/j.jiac.2019.01.003. Epub 2019 Feb 2. J Infect Chemother. 2019. PMID: 30718192
Detection of subclonal SETBP1 and JAK3 mutations in juvenile myelomonocytic leukemia using droplet digital PCR.
Wakamatsu M, Okuno Y, Murakami N, Miwata S, Kitazawa H, Narita K, Kataoka S, Ichikawa D, Hamada M, Taniguchi R, Suzuki K, Kawashima N, Nishikawa E, Narita A, Nishio N, Kojima S, Muramatsu H, Takahashi Y. Wakamatsu M, et al. Among authors: narita k, narita a. Leukemia. 2021 Jan;35(1):259-263. doi: 10.1038/s41375-020-0817-x. Epub 2020 Apr 20. Leukemia. 2021. PMID: 32307441 No abstract available.
Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor.
Kataoka S, Kawashima N, Okuno Y, Muramatsu H, Miwata S, Narita K, Hamada M, Murakami N, Taniguchi R, Ichikawa D, Kitazawa H, Suzuki K, Nishikawa E, Narita A, Nishio N, Yamamoto H, Fukasawa Y, Kato T, Yamamoto H, Natsume J, Kojima S, Nishino I, Taketani T, Ohnishi H, Takahashi Y. Kataoka S, et al. Among authors: narita k, narita a. J Allergy Clin Immunol. 2021 Aug;148(2):639-644. doi: 10.1016/j.jaci.2021.03.010. Epub 2021 Mar 13. J Allergy Clin Immunol. 2021. PMID: 33727065
Clinical diagnostic value of telomere length measurement in inherited bone marrow failure syndromes.
Miwata S, Narita A, Okuno Y, Suzuki K, Hamada M, Yoshida T, Imaya M, Yamamori A, Wakamatsu M, Narita K, Kitazawa H, Ichikawa D, Taniguchi R, Kawashima N, Nishikawa E, Nishio N, Kojima S, Muramatsu H, Takahashi Y. Miwata S, et al. Among authors: narita k, narita a. Haematologica. 2021 Sep 1;106(9):2511-2515. doi: 10.3324/haematol.2021.278334. Haematologica. 2021. PMID: 33882640 Free PMC article. No abstract available.
Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia.
Kitazawa H, Okuno Y, Muramatsu H, Aoki K, Murakami N, Wakamatsu M, Suzuki K, Narita K, Kataoka S, Ichikawa D, Hamada M, Taniguchi R, Kawashima N, Nishikawa E, Narita A, Nishio N, Hama A, Loh ML, Stieglitz E, Kojima S, Takahashi Y. Kitazawa H, et al. Among authors: narita k, narita a. Blood Adv. 2021 Dec 28;5(24):5507-5518. doi: 10.1182/bloodadvances.2021005080. Blood Adv. 2021. PMID: 34580726 Free PMC article.
Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma.
Imaya M, Muramatsu H, Narita A, Yamamori A, Wakamatsu M, Yoshida T, Miwata S, Narita K, Ichikawa D, Hamada M, Nishikawa E, Kawashima N, Nishio N, Kojima S, Takahashi Y. Imaya M, et al. Among authors: narita k, narita a. Cancer Med. 2022 May;11(9):1956-1964. doi: 10.1002/cam4.4529. Epub 2022 Mar 1. Cancer Med. 2022. PMID: 35233973 Free PMC article.
749 results